Physician profile

Juan C Rozo

Cardiovascular Disease · Shenandoah, TX

NPI 1639164239

$12,200.12

in general payments reported to CMS, 2019-2025

51 companies · $1,134 in 2025

The $1,134 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,993.09
Travel and Lodging$808.15

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $3,210.85 2019-2025 Watchman Flx, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor
Novartis Pharmaceuticals Corporation $1,223.56 2019-2025
Medtronic Vascular, INC. $1,072.21 2019-2020
Abbott Laboratories $1,069.92 2019-2025 Cardiomems, Mitraclip, Ensite
Medtronic, INC. $837.76 2021-2025 Corevalve Evolut R, Venaseal, Endurant Iis
Amgen INC. $750.64 2019-2025 Repatha, Repatha
E.R. Squibb & Sons, L.L.C. $408.39 2020-2025 Camzyos, Eliquis
Impulse Dynamics (USA) INC. $385.60 2021-2023 Optimizer
Merck Sharp & Dohme LLC $313.23 2021-2024 Verquvo
Boehringer Ingelheim Pharmaceuticals, INC. $308.90 2020-2024 Jardiance
Janssen Pharmaceuticals, INC $257.35 2019-2022
Atricure, INC. $230.59 2024-2025 Synergy Ablation System
Cvrx, INC. $210.25 2019-2024 Barostim Neo System
Tactile Systems Technology INC $149.20 2019-2022
Amarin Pharma, INC. $142.97 2019-2020
Show all 51 companies
CompanyGeneral paymentsYearsTop products
Cleerly, INC. $138.03 2024-2025 Cleerly Labs, Cleerly Ischemia
Astrazeneca Pharmaceuticals LP $101.64 2019-2025 Wainua, Andexxa
Baxter Healthcare $90.18 2023-2024 Hillrom - Carnation Ambulatory Monitor, Coseal
Venclose INC. $78.78 2020
Heartflow, INC. $77.60 2019-2022
Elutia, INC. $75.44 2021-2022
Sanofi-Aventis U.S. LLC $67.36 2019-2022
Imperative Care, INC $67.31 2024 Prodigy Catheter
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $63.18 2019-2025 Lifevest
Siemens Medical Solutions USA, INC. $52.03 2019-2022
Ge Healthcare $51.28 2019-2023
Pfizer INC. $50.33 2020-2023
Becton, Dickinson and Company $49.22 2023 Avitene Ultrafoam
Bard Peripheral Vascular, INC. $46.19 2024 Venclose Maven Catheter
Actelion Pharmaceuticals US, INC. $46.00 2019-2021
Astellas Pharma US INC $45.14 2019
Innovation Technologies INC $43.90 2024 Irrisept
Smith+Nephew, INC. $42.12 2022
Novo Nordisk INC $41.88 2021-2024 Rybelsus, Ozempic
Kiniksa Pharmaceuticals, LTD. $40.91 2023 Arcalyst
Regeneron Healthcare Solutions, INC. $36.86 2024 Evkeeza
Bardy Diagnostics, INC. $35.00 2019-2020
Cardiva Medical, INC. $29.63 2024 Savvywire
Edwards Lifesciences Corporation $28.01 2024 Mitris Resilia Mitral Valve
Chiesi USA, INC. $27.71 2020-2021
Biocompatibles, INC. $26.17 2019
Silk Road Medical, INC. $22.59 2019
Dexcom, INC. $21.74 2025 Dexcom G6 Transmitter
Esperion Therapeutics, INC. $18.81 2023 Nexletol
Polynovo North America LLC $18.55 2023
Biotissue Holdings INC. $18.06 2024
Strongbridge US INC. $17.09 2019
Bayer Healthcare Pharmaceuticals INC. $16.55 2025
Irhythm Technologies, INC. $16.08 2024 Zio Monitor, Zio Xt Patch
G Medical Diagnostic Services, INC. $14.30 2022
Acell, INC. $13.03 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Juan C Rozo

$12,200.12

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $1,134 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/255208/juan-c-rozo

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.